MYERS MICHAEL (Chief Executive Officer) purchased 119.0% of their position (20.49K shares) of QUOIN PHARMACEUTICALS, LTD. on the open market
Open‑market purchase worth $100.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/2/2026ACC: 0001104659-26-104404
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+30.73K
Net shares
Net buyer
$100.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
30.73K acquired
Non-Derivative Transactions1
ADSs
Direct
Shares
+20.49K
Price / share
$4.88
Trade value
$99.99K
% of position
119.0%
8/31/2026
17.22K→37.71K
Total
Net shares
+20.49K
Net value
$99.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ADSs Direct | 8/31/2026 | P · Purchase | +20.49K | $4.88 | $99.99K | 119.0% | 17.22K | 37.71K |
| Total | +20.49K | $99.99K | ||||||
Derivative Transactions1
Ordinary Warrants (Right to Buy)
Direct
Converts to
ADS
10.24K shares
Shares
+10.24K
Strike price
6.10
Held after
10.24K
Exercisable
—
8/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Ordinary Warrants (Right to Buy) Direct | ADS10.24K shares | 8/31/2026 | P · Purchase | +10.24K | 6.10 | — | 10.24K |